Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - technology+classifications+%3e+vaccines
16
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Targeted Organ or Multiple Organ Delivery of mRNA with Ionizable Amphiphilic Janus Dendrimers
A library of easily synthesized ionizable amphiphilic Janus dendrimer (IAJD) compounds that deliver mRNA either to targeted organs or multiple organs, depending on the IAJD design. Problem: Four-component lipid nanoparticles (LNPs) are the benchmark synthetic vector for the delivery of mRNA. Despite their high biosafety, low toxicity, and immunogenicity,...
Published: 7/23/2024
|
Inventor(s):
Virgil Percec
,
Drew Weissman
,
Juncheng (Luke) Lu
,
Elena Atochina-Vasserman
,
Devendra Maurya
,
Dipankar Sahoo
Keywords(s):
Drug Delivery
,
Platform Technology
Category(s):
Technology Classifications > Chemical Processes and Synthesis
,
Technology Classifications > Vaccines
Universal cancer vaccine targeting tumor vasculature
A DNA vaccine targeting tumor endothelial marker 1 (TEM1) that allows to prevent and delay tumor progression without adverse effect on physiologic angiogenesis Technology Overview: Immunization against antigens specifically expressed on tumor vasculature is a very attractive immunotherapy options due to its ability to prevent solid tumor growth....
Published: 6/21/2024
|
Inventor(s):
George Coukos
Keywords(s):
Oncology
Category(s):
Technology Classifications > Vaccines
Immune Modulator Encoded Lipid Nanoparticle Formulation Improves T Cell Response to Vaccines
Researchers developed an LNP-mRNA-based vaccine that encodes different cytokine mRNAs, as a method to enhance CD8+ T cell responses and memory formation. Problem: Lipid nanoparticles (LNPs) are an emerging technique to deliver mRNA in vivo more efficiently. While recent progress in mRNA technology has allowed the rapid development of SARS-COV2 vaccines,...
Published: 7/2/2024
|
Inventor(s):
Christopher Hunter
,
Drew Weissman
,
Mohamad Alameh
,
Emily Aunins
,
Anthony Phan
Keywords(s):
Bioengineering
,
Drug Delivery
,
Immunology
,
Immunoncology
,
Immunotherapy
,
Infectious Disease
,
Nanotechnology
Category(s):
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
Modified Antimicrobial Peptides For Enhanced Antibiotic Properties
Modified antimicrobial peptides with protein sequences for augmenting antimicrobial and antibiofilm properties. Problem: Antibiotic resistant bacteria are becoming more prevalent, while antibiotic innovation has slowed. Novel antimicrobial agents are needed to treat the 35,000 annual deaths from antibiotic resistant infections. While antimicrobial...
Published: 5/7/2024
|
Inventor(s):
Cesar de la Fuente-Nunez
,
Marcelo Der Torossian Torres
,
Octavio Franco
Keywords(s):
Bioengineering
,
Infectious Disease
,
Protein/Peptide (Non-Antibody)
Category(s):
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
Direct and Effective Method To Reverse The Effects of Fragile X Syndrome
A method of treating Fragile X syndrome by correcting the abnormal DNA clusters causing the characteristic symptoms. Problem: Fragile X syndrome (FXS) affects approximately 1 in 4,000 males and 1 in 8,000 females and is characterized by symptoms such as: Inherited Intellectual Disability Anxiety Attention Deficit Disorder (ADD) Skin, Ovaries...
Published: 3/8/2024
|
Inventor(s):
Jennifer Phillips-Cremins
,
Linda Zhou
,
Chunmin GE
Keywords(s):
Bioengineering
,
Gene Therapy
,
Genetic Disorders
,
Neurodegenerative Diseases
,
Neurology
Category(s):
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
RGD Peptide-Based Lipids For Targeted mRNA Delivery and Gene Editing Applications
A combinatorial library of RGD peptide (arginine-glycine-aspartic acid)-based lipids designed to formulate lipid nanoparticles for targeted mRNA delivery to the liver and the spleen. Problem: Lipid Nanoparticles (LNPs) are becoming an established choice of vehicle to deliver mRNA-based therapeutics, including vaccines, protein replacement therapies,...
Published: 2/7/2024
|
Inventor(s):
Michael Mitchell
,
Lulu Xue
,
Jingya Qin
Keywords(s):
Bioengineering
,
Drug Delivery
,
Gene Editing
,
Oncology
,
Platform Technology
Category(s):
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
Modified Lipid Nanoparticle Formulations with Improved Therapeutic Delivery to the Bone Microenvironment In-vivo
A library of bi-phosphonate ionizable lipids and LNP formulations to facilitate mRNA delivery to the bone microenvironment. Problem: The increasing prevalence of skeletal diseases such as osteoporosis, osteoarthritis and bone cancer have motivated efforts to target the bone microenvironment therapeutically. However, therapeutic agents must overcome...
Published: 2/7/2024
|
Inventor(s):
Michael Mitchell
,
Lulu Xue
Keywords(s):
Drug Delivery
,
Drug Target
,
Nanotechnology
,
Orthopedics
,
Platform Technology
,
Regenerative Medicine
Category(s):
Technology Classifications > Vaccines
,
Technology Classifications > Therapeutics
,
Technology Classifications > Research Tools & Reagents
Ligand-Tethered Lipid Nanoparticles for Targeted RNA Delivery to Treat Liver Fibrosis
A new class of anisimide-functionalized lipids that enables targeted delivery of lipid nanoparticles (LNPs) to activated fibroblasts in the liver. Problem: Lipid nanoparticles (LNPs) have been successfully used in FDA-approved therapies to deliver messenger RNA (mRNA) and small interfering RNA (siRNA) . One of the biggest challenge in developing...
Published: 2/7/2024
|
Inventor(s):
Michael Mitchell
,
Xuexiang Han
Keywords(s):
Bioengineering
,
Drug Delivery
,
Gene Editing
,
Gene Therapy
,
Genetic Disorders
,
Immunology
,
Immunoncology
,
Platform Technology
,
Regenerative Medicine
Category(s):
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
Engineered Wasp Venom for Safe and Effective Antibiotics
A method for manipulating wasp venom peptide to maintain antimicrobial properties while reducing human toxicity. Problem: Almost 20% of global deaths (~11 million) are from sepsis, often caused by bacterial infections. 35,000 of these deaths are due to drug-resistant bacteria, which are becoming more prevalent. Drug-resistant bacteria are also dangerous...
Published: 10/16/2023
|
Inventor(s):
Marcelo Der Torossian Torres
,
Cesar de la Fuente-Nunez
Keywords(s):
Bioengineering
,
Infectious Disease
,
Inflammation
,
Protein/Peptide (Non-Antibody)
Category(s):
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
CD137 enrichment of tumor-specific tumor-infiltrating lymphocytes (TILs)
A platform to isolate and expand CD137-positive (CD137pos) tumor-infiltrating lymphocytes (TILs) to use in adoptive immunotherapy and translational studies. Problem: Adoptive immunotherapy using either naturally occurring or genetically modified tumor-infiltrating lymphocytes (TILs) is being developed to treat solid tumors clinically. However, methods...
Published: 4/2/2024
|
Inventor(s):
Daniel Powell
Keywords(s):
CAR T-cell Enhancing Technology
,
Cell Therapy
,
Immunology
,
Immunoncology
,
Immunotherapy
,
Oncology
,
Platform Technology
Category(s):
Technology Classifications > Research Tools & Reagents
,
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
1
2